MedPath

Turning the tide of antimicrobial resistance in intensive care units in Indonesia

Recruiting
Conditions
Antimicrobial resistance, Intensive care
Registration Number
NL-OMON26918
Lead Sponsor
1.Faculty of Medicine Universitas Indonesia / Dr Cipto Mangunkusumo Hospital Jakarta, Indonesia2. Erasmus MC Rotterdam, The Netherlands
Brief Summary

The study is published in the journal 'Antimicrobial Resistance and Infection Control'. DOI 10.1186/s13756-017-0296-7.

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
550
Inclusion Criteria

All adult patients (age ≥18 years old) admitted to the intensive care unit of Dr Cipto Mangunkusumo Hospital in Jakarta, Indonesia.

Exclusion Criteria

Patients who are discharged within 48 hours from the intensive care unit.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The number of patients who acquire carriage or infection with A. baumannii with reduced susceptibility to carbapenems, P. aeruginosa with reduced susceptibility to carbapenems, or K. pneumoniae with reduced susceptibility to carbapenems per 100 patient-days at risk in the ICU. <br /><br>An acquisition is defined as a screening culture (throat or rectum) or clinical culture with a first detection of either A. baumannii, P. aeruginosa, or K. pneumoniae, all with reduced susceptibility to a carbapenem, that was not yet present on admission or in the first 48 hours of admission. Thus, for each patient, a maximum of three new acquisition events may occur.
Secondary Outcome Measures
NameTimeMethod
Measures include quantity and quality of antibiotic usage, the in-ICU crude mortality rate, the hand hygiene compliance of health care workers, and environmental contamination of the above mentioned Gram-negative bacteria with reduced susceptibility to carbapanems.
© Copyright 2025. All Rights Reserved by MedPath